Recently diagnosed with HIV? Click here

New non-nuke approved

Positive Living article • Adrian Ogier • 5 June 2009

A new Non-Nucleoside Reverse Transcriptase InhibitorA type of anti-HIV drug which works by interfering with an enzyme, reverse transcriptase, that HIV needs to reproduce. – etravirine – will be listed on the Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. (PBS) from July 1.

Non-nukes form an important backbone of many people’s drug regimens however resistance to the two others currently prescribed – nevirapine and efavirenz – is common. Fortunately, etravirine has proved effective in many people who are resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant. to these drugs.

Its addition to the antiretroviralsA medication or other substance which is active against retroviruses such as HIV. currently available in Australia will benefit many of the more treatment-experienced. Its indication for use targets those who have had at least three treatment combinations fail in their therapy history.

  • Delicious
  • Digg
  • StumbleUpon
  • Reddit
  • Facebook
  • Google
  • Yahoo
  • Technorati
Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

From Positive Living

This article was first published in the June 2009 issue of Positive Living — more than one year ago.

While the content of this was checked for accuracy at the time of publication, NAPWA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.

This article may contain medical information. NAPWA makes every reasonable effort to ensure the information on this website is accurate, reliable and up-to-date, including obtaining technical reviews by medically-qualified reviewers, however the authors of information on this website are not qualified to give medical advice, except where explicitly stated.

The content of this website is intended to support, not replace, the relationship between people living with HIV/AIDS and their medical advisers, and is not intended as a substitute for medical advice.

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.

more